We further analyzed the effect of TBC1D9 expression on survival outcome of BC patients and found that the low expression of TBC1D9 correlates with poor survival outcome for RFS (p = 1.5 × 10−13, Figure 1B) and OS (p = 1.5 × 10−5, Figure 1C). This evidence concerns the gene TBC1D9 and breast cancer.